Effect of ivabradine on recurrent hospitalization for worsening heart failure in patients with chronic systolic heart failure: the SHIFT Study

AIMS: We explored the effect of treatment with ivabradine, a pure heart rate-slowing agent, on recurrent hospitalizations for worsening heart failure (HF) in the SHIFT trial. METHODS AND RESULTS: SHIFT was a double-blind clinical trial in which 6505 patients with moderate-to-severe HF and left ventr...

Descripción completa

Detalles Bibliográficos
Autores principales: Borer, Jeffrey S., Böhm, Michael, Ford, Ian, Komajda, Michel, Tavazzi, Luigi, Sendon, Jose Lopez, Alings, Marco, Lopez-de-Sa, Esteban, Swedberg, Karl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2012
Materias:
Esc Fasttrack
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3498004/
https://www.ncbi.nlm.nih.gov/pubmed/22927555
http://dx.doi.org/10.1093/eurheartj/ehs259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3498004/
https://www.ncbi.nlm.nih.gov/pubmed/22927555
http://dx.doi.org/10.1093/eurheartj/ehs259

Ejemplares similares